Senegal’s $7.1m sickle cell drug push targets six African markets

Senegal’s $7.1m sickle cell drug push targets six African markets

Senegal is stepping up efforts to reduce Africa’s dependence on imported medicines with a $7.1 million pharmaceutical project producing a

read more Senegal’s $7.1m sickle cell drug push targets six African markets

Originally published by BusinessDay.

Read the full article on BusinessDay →

2026 Afropolitain Magazine